Insider trades
RA Capital Nexus Fund, Director of Climb Bio CLYM, has filed 32 purchases and 65 sales on the open market. Over the past 12 months that comes to a net purchase of $49.7M. The latest trade was on 09/28.
RA Capital Nexus Fund
Director
- Company
- Climb Bio CLYM
- First filing
- 23/03/30
- Trades
- 183 trades
- Buys / sales
- 32 / 65
- 12-month net buying
- $49.7M
- Last trade
- 09/28
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
ARTV | Open-market buy | 06/25–06/26 | 06/29 | 32,876 sh2 trades | $8.89avg. | $292,126.48 | +0.2% |
ARTV | Open-market buy | 06/12–06/16 | 06/16 | 531,326 sh3 trades | $8.66avg. | $4,599,903.46 | +3.3% |
ARTV | Open-market buy | 06/09–06/11 | 06/11 | 1,027,722 sh3 trades | $7.44avg. | $7,650,148.29 | +6.8% |
| Open-market buy | 05/11 | 05/13 | 6,510,416 sh | $11.52 | $74,999,992.32 | +74.9% | |
Climb BioCLYM | Open-market buy | 01/05 | 01/07 | 7,111 sh | $3.50 | $24,888.5 | +0.2% |
CLYM | Open-market buy | 25/12/11–25/12/12 | 25/12/15 | 314,561 sh2 trades | $2.40avg. | $754,737.14 | +10.2% |
SION | Open-market sale | 25/11/20–25/11/21 | 25/11/24 | 30,316 sh12 trades | $39.61avg. | $1,200,703.87 | −16.0% |
SION | Open-market sale | 25/11/17–25/11/19 | 25/11/19 | 136,351 sh24 trades | $40.34avg. | $5,500,158.01 | −44.8% |
SION | Open-market sale | 25/10/24–25/10/28 | 25/10/28 | 373,610 sh8 trades | $39.51avg. | $14,762,603.8 | −64.1% |
VOR | Open-market sale | 25/10/20–25/10/21 | 25/10/22 | 117,050 sh5 trades | $29.34avg. | $3,433,992.06 | −7.7% |
VOR | Open-market sale | 25/10/15–25/10/17 | 25/10/17 | 464,025 sh16 trades | $29.54avg. | $13,707,361.09 | −96.8% |
TYRA | Open-market buy | 25/06/12–25/06/16 | 25/06/16 | 163,287 sh3 trades | $10.19avg. | $1,664,700.49 | +1.6% |
Tyra BiosciencesTYRA | Open-market buy | 25/06/09 | 25/06/11 | 186,850 sh | $10.19 | $1,904,001.5 | +1.9% |
TYRA | Open-market buy | 25/06/04–25/06/05 | 25/06/06 | 1,211,198 sh2 trades | $9.70avg. | $11,751,303.68 | +13.9% |
SION | Open-market buy | 25/02/10 | 25/02/10 | 1,125,000 sh2 trades | $18.00avg. | $20,250,000 | +93.8% |
| Open-market buy | 25/01/30 | 25/02/03 | 5,714,285 sh | $8.75 | $49,999,993.75 | +41.3% | |
Tyra BiosciencesTYRA | Open-market buy | 24/11/08 | 24/11/13 | 1,220,681 sh | $16.25 | $19,836,066.25 | +16.3% |
ARTV | Open-market buy | 24/07/22 | 24/07/24 | 8,333,333 sh2 trades | $12.00avg. | $99,999,996 | No record |
CLYM | Open-market buy | 24/06/27 | 24/07/01 | 13,008,546 sh2 trades | $3.84avg. | $49,952,816.64 | No record |
Jade BiosciencesJBIO | Open-market buy | 24/06/17 | 24/06/20 | 928,110 sh | $1.67 | $1,549,943.7 | +13.3% |
